Asset and Brand planning – what do we do differently when the future has shifted?
With much talk of a changed pharma and biotech market landscape, we ask Jon Bircher, Chief Commercial Officer of Cello Health, and Carl...
With much talk of a changed pharma and biotech market landscape, we ask Jon Bircher, Chief Commercial Officer of Cello Health, and Carl...
One of the greatest challenges in the early stages of asset development is the data and evidence gap; development teams’ foundation of...
When you consider the value of an asset, it can effectively be expressed as the integration of several variables over the lifetime of the...
As a free user, you can follow Passle and like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net